An injectable depot system for sustained intraperitoneal chemotherapy of ovarian cancer results in favorable drug distribution at the whole body, peritoneal and intratumoral levels-Reference-Cited by-同舟云学术

An injectable depot system for sustained intraperitoneal chemotherapy of ovarian cancer results in favorable drug distribution at the whole body, peritoneal and intratumoral levels

Published:2012-03 Issue:3 Volume:158 Page:379-385
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Zahedi Payam,Stewart James,De Souza Raquel,Piquette-Miller Micheline,Allen Christine

Funder

Canadian Cancer Society, Ontario Division

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference54 articles.

1. Ovarian Cancer;Cho;Annu. Rev. Pathol. Mech. Dis.,2009

2. Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence;Ceelen;Nat. Rev. Clin. Oncol.,2010

3. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer;Alberts;N. Engl. J. Med.,1996

4. Intraperitoneal cisplatin and paclitaxel in ovarian cancer;Armstrong;N. Engl. J. Med.,2006

5. Phase III Trial of Standard-Dose Intravenous Cisplatin Plus Paclitaxel Versus Moderately High-Dose Carboplatin Followed by Intravenous Paclitaxel and Intraperitoneal Cisplatin in Small-Volume Stage III Ovarian Carcinoma: An Intergroup Study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intraperitoneal drug delivery systems for peritoneal carcinomatosis: Bridging the gap between research and clinical implementation;Journal of Controlled Release;2024-09

2. Pharmacokinetic evaluation of poorly soluble compounds formulated as nano- or microcrystals after intraperitoneal injection to mice;International Journal of Pharmaceutics;2023-04

3. Nanoparticles of VAV1 siRNA combined with LL37 peptide for the treatment of pancreatic cancer;Journal of Controlled Release;2023-03

4. Intraperitoneal Delivery Systems;Exploring Drug Delivery to the Peritoneum;2023

5. mPEG-PDLLA Micelles Potentiate Docetaxel for Intraperitoneal Chemotherapy in Ovarian Cancer Peritoneal Metastasis;Frontiers in Pharmacology;2022-04-06